This is nothing but more obfuscation and outright delay. Most notably, if first dose for the Eltoprazine study was due this year, the funding would be set, and the Principal investigator would be set among other things. I could go on, but not now.
If the pps trades up because of this CC then well, I would take that data to someone who understands it and go from there.
News 
Market Data 
Discover 
